Dr. Sarvestani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Holmes St
Kansas City, MO 64108Phone+1 816-404-1000
Education & Training
University of Missouri Kansas City School of MedicineClass of 2019
Certifications & Licensure
MO State Medical License 2019 - 2025
DC State Medical License 2021 - 2024
Publications & Presentations
PubMed
- 3 citationsSelpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers.Amber Leila Sarvestani, Jacob Lambdin, Mimi Hu, Maria Cabanillas, Steven G Waguespack
Annals of Surgical Oncology. 2024-04-01 - 9 citationsA Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032).Areeba Saif, Emily A Verbus, Amber Leila Sarvestani, Martha E Teke, Jacob Lambdin
Annals of Surgical Oncology. 2023-02-01 - 2 citationsMitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After Surgery.Amber Leila Sarvestani, Stephanie N Gregory, Martha E Teke, Massimo Terzolo, Alfredo Berruti
Annals of Surgical Oncology. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
